HEMAS HOLDINGS PLC (HHL.N0000)

SUSPENS wrote:Big fish turn to catch ....will update...

Already collected 165,000

SUSPENS wrote:Big fish turn to catch ....will update...

Already collected 165,000

judecroos wrote:HHL may have sold SHOT today.

LOLC Group acquires Hemas Group’s Serendib Hotels


15 December 2020 11:57 am - 0 - 1170

A A A

---

judecroos wrote:HHL may have sold SHOT today.







LOLC Group acquires Hemas Group’s Serendib Hotels


15 December 2020 11:57 am - 0 - 1170

A A A

---

LOLC Group today acquired the hospitality arm of Hemas Holdings PLC in a deal worth over Rs.600 million.

Brokers said Hemas Holdings this morning divested its entire stake of 42.8 million shares of Serendib Hotels PLC, which constitutes to 56.6 percent of the issued shares of the company to LOLC Group.

The shares were purchased at Rs.14.20 each. The net asset value of Serendib Hotels PLC as at September 30, 2020 was Rs.18.78.

The acquisition will trigger a mandatory offer.

Serendib Hotels PLC owns and operates Avani Bentota Resort at Bentota, formerly known as Serendib Hotel.

Meanwhile, Serendib Hotels PLC is the major shareholder of Hotel Sigiriya PLC, which owns Hotel Sigiriya in Sigiriya and of Dolphin Hotels PLC, which owns Club Hotel Dolphin in Waikkal.

The company fully owns and operates Frontier Capital Lanka (Pvt) Ltd., which owns the Lantern Beach Collection in Mirissa.

Serendib Leisure Management Limited, a fully owned subsidiary of the company, manages all the above properties.

It also has a 5.9 percent stake in Jada Resort & Spa (Pvt) Ltd, which owns Avani and Anantara Kalutara Resorts in Kalutara.

LOLC Group is headed by dynamic business leader Ishara Nanayakkar

judecroos wrote:

judecroos wrote:HHL may have sold SHOT today.







LOLC Group acquires Hemas Group’s Serendib Hotels


15 December 2020 11:57 am - 0 - 1170

A A A

---

LOLC Group today acquired the hospitality arm of Hemas Holdings PLC in a deal worth over Rs.600 million.

Brokers said Hemas Holdings this morning divested its entire stake of 42.8 million shares of Serendib Hotels PLC, which constitutes to 56.6 percent of the issued shares of the company to LOLC Group.

The shares were purchased at Rs.14.20 each. The net asset value of Serendib Hotels PLC as at September 30, 2020 was Rs.18.78.

The acquisition will trigger a mandatory offer.

Serendib Hotels PLC owns and operates Avani Bentota Resort at Bentota, formerly known as Serendib Hotel.

Meanwhile, Serendib Hotels PLC is the major shareholder of Hotel Sigiriya PLC, which owns Hotel Sigiriya in Sigiriya and of Dolphin Hotels PLC, which owns Club Hotel Dolphin in Waikkal.

The company fully owns and operates Frontier Capital Lanka (Pvt) Ltd., which owns the Lantern Beach Collection in Mirissa.

Serendib Leisure Management Limited, a fully owned subsidiary of the company, manages all the above properties.

It also has a 5.9 percent stake in Jada Resort & Spa (Pvt) Ltd, which owns Avani and Anantara Kalutara Resorts in Kalutara.

LOLC Group is headed by dynamic business leader Ishara Nanayakkar

https://www.theequitycheck.com/filedata/fetch?id=48137&d=1608025408

MoneyLover wrote:

judecroos wrote:LOLC Group acquires Hemas Group’s Serendib Hotels

---

HHL is slowly becoming another SUN. Unlike many conglomerates, it divested many businesses;
Years ago they divested the Power & Energy sector, thereafter ICT business. At the beginning of this year Travel business, and now the Leisure sector.  

I think their strategy is to concentrate on Pharmaceutical Health Care and FMCG, which are less risky. We can expect that HHL invest more in Pharmaceutical & Health Care especially Pharmaceutical manufacturing benefitting from favorable government policy.

Hemas Pharmaceuticals – First Pharmaceutical Company in Sri Lanka to be Awarded COVID-19 Safety Management System Certification

CSEdeSILVA wrote:

Hemas Pharmaceuticals – First Pharmaceutical Company in Sri Lanka to be Awarded COVID-19 Safety Management System Certification

Hemas Pharmaceuticals becomes the first pharmaceutical company in Sri Lanka to be awarded the SLS 1672:2020 COVID-19 Safety Management System Certification from the Sri Lanka Standards Institution (SLSI). The certification has been awarded as a result of the company’s relevance, rigor and consistency in the implementation and reinforcement of best in class safety management practices to minimize the risks of COVID-19 within its work locations

As an organization that prioritizes making healthful living happen amongst the families of our nation, Hemas Pharmaceuticals actively works towards ensuring the health and safety of its employees from the risks of COVID-19 in its work locations.

Sharing his thoughts on the certification, Mr. Jude Fernando Managing Director of Hemas Pharmaceuticals said, “Creating a healthier nation begins first by ensuring the health and safety of our own employees from the risks of COVID-19 in our work locations during the current pandemic situation. We are proud to be the first in the industry and among very few corporates in Sri Lanka to have this endorsement at the highest level from The Sri Lanka Standards Institution for our COVID -19 related Health and Safety efforts.”

The COVID -19 Safety Management System  Certification from the Sri Lanka Standards Institution (SLSI) pledges that the  certified organization’s  health and safety procedures are in adherence with governmental requirements, and this indicates  that Hemas Pharmaceuticals (Pvt) Ltd and Hemas Surgical and Diagnostics (Pvt) Ltd provides the assurance to its customers and the general public on the uninterrupted supply of pharmaceuticals in this pandemic period.

http://bizenglish.adaderana.lk/hemas-pharmaceuticals-first-pharmaceutical-company-in-sri-lanka-to-be-awarded-covid-19-safety-management-system-certification/